CanaFarma Hemp Products Corp. (CNFHF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerCanaFarma Hemp Products Corp. (CNFHF) trades at $0.0001. CanaFarma Hemp Products Corp. focuses on the hemp-based products market, offering items like chewing gum and tinctures under the YOOFORIC brand. Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for CNFHF: CNFHF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CNFHF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
CNFHF: the 2 scored disciplines are evenly split. Dominant signal: Izzy Englander bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
CanaFarma Hemp Products Corp. (CNFHF) Healthcare & Pipeline Overview
CanaFarma Hemp Products Corp. is a Canadian-based company focused on the U.S. hemp market, manufacturing and selling hemp-based products such as chewing gum and tinctures under its YOOFORIC brand. The company operates primarily online, facing competition in the rapidly evolving specialty and generic drug manufacturing sector.
What Is the Investment Thesis for CNFHF?
Investing in CanaFarma Hemp Products Corp. presents a high-risk, high-reward scenario. The company's negative profit margin of -986.7% and gross margin of -132.1% indicate significant financial challenges. CanaFarma operates in a rapidly evolving and highly competitive market, requiring substantial capital to achieve scale and brand recognition. Growth catalysts include potential regulatory changes that could expand the market for hemp-derived products and successful product innovation. However, the company's financial viability depends on achieving profitability and managing its cash flow effectively. Investors should carefully consider the risks associated with investing in a small-cap company in a nascent and highly regulated industry.
Based on FMP financials and quantitative analysis
CNFHF Key Highlights
Market Cap: $0.00B indicates the company is a micro-cap stock with limited liquidity.
- P/E Ratio: -0.00 reflects the company's current lack of profitability.
- Profit Margin: -986.7% suggests significant operational inefficiencies and high costs relative to revenue.
- Gross Margin: -132.1% indicates that the cost of goods sold exceeds revenue, posing a serious challenge to the company's business model.
- Beta: -0.05 suggests the stock has a low correlation with the overall market, potentially offering diversification benefits but also indicating limited investor interest.
Who Are CNFHF's Competitors?
CNFHF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BGXX Bright Green Corporation | $0.04 | +5328.57% | $7.26M | — |
| AVCNF Avicanna Inc. | $0.08 | 0.00% | $10.6M | — |
| PLNH Planet 13 Holdings Inc. | $0.13 | -7.14% | $42.7M | — |
| DBCCF Decibel Cannabis Company Inc. | $1.27 | -3.39% | $49.0M | — |
| ZYBT Zhengye Biotechnology Holding Limited | $1.59 | +1.27% | $75.4M | — |
| CWBHF Charlotte's Web Holdings, Inc. | $0.33 | -3.93% | $88.4M | — |
| AAWH Ascend Wellness Holdings, Inc. | $0.49 | +1.36% | $98.7M | — |
| BGM BGM Group Ltd. | $0.28 | +0.92% | $105M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CNFHF's Key Strengths?
Established brand (YOOFORIC).
- Vertically integrated operations.
- Online distribution channel.
- Focus on hemp-based products.
What Are CNFHF's Weaknesses?
Negative profit margin.
- Limited product line.
- Small market capitalization.
- Dependence on the U.S. market.
What Could Drive CNFHF Stock Higher?
Potential changes in regulations regarding hemp-derived products could expand the market.
- Increasing consumer awareness and acceptance of hemp-based products.
- Expansion of the company's product line to include new hemp-derived offerings.
What Are the Key Risks for CNFHF?
Financial-distress signal — its Altman Z-Score of -44.29 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition in the hemp-based products market.
- Evolving regulations could restrict the sale or marketing of hemp products.
- Negative profit margin and financial instability.
- Dependence on the U.S. market.
- Limited access to capital.
What Are the Growth Opportunities for CNFHF?
- Expansion of Product Line: CanaFarma can expand its product line beyond chewing gum and tinctures to include other hemp-derived products such as topicals, edibles, and beverages. Successful product innovation and diversification could drive revenue growth and increase market share. Timeline: 1-2 years.
- Strategic Partnerships: CanaFarma can form strategic partnerships with established retailers, distributors, and healthcare providers to expand its distribution network and reach a wider customer base. Collaborations with established players can provide access to valuable resources, expertise, and market channels. This can significantly improve market penetration. Timeline: Ongoing.
- E-commerce Optimization: CanaFarma can optimize its online platform to improve the customer experience, increase conversion rates, and drive online sales. Investing in user-friendly website design, targeted marketing campaigns, and efficient order fulfillment processes can enhance customer satisfaction and loyalty. The e-commerce channel offers a cost-effective way to reach a global audience. Timeline: Ongoing.
- International Expansion: CanaFarma can explore opportunities to expand its operations into international markets where hemp-derived products are legal and in demand. Entering new markets can diversify revenue streams and reduce reliance on the U.S. market. However, international expansion requires careful planning and compliance with local regulations. Timeline: 2-3 years.
- Research and Development: CanaFarma can invest in research and development to develop innovative hemp-derived products with enhanced efficacy and unique formulations. Conducting clinical trials and scientific studies can validate the health benefits of its products and differentiate them from competitors. This can lead to the development of proprietary formulations and intellectual property. Timeline: Ongoing.
What Are CNFHF's Competitive Advantages?
- Brand recognition (YOOFORIC brand).
- Proprietary formulations.
- Vertically integrated supply chain.
- Online distribution channel.
What Does CNFHF Do?
CanaFarma Hemp Products Corp., based in Vancouver, Canada, is involved in the cultivation, manufacturing, processing, and sale of hemp oil within the United States. The company's product line includes hemp-based chewing gum and tinctures marketed under the YOOFORIC brand. These products are primarily sold through the company's online platform. CanaFarma focuses on tapping into the growing market for hemp-derived products, particularly those perceived to offer wellness benefits. The company's business model centers on vertically integrating aspects of the hemp supply chain, from cultivation to retail distribution, to maintain control over product quality and supply. CanaFarma aims to capitalize on the increasing consumer interest in alternative health and wellness products derived from hemp. However, the company operates in a highly competitive and evolving regulatory landscape, requiring it to adapt to changing market conditions and legal frameworks.
What Products and Services Does CNFHF Offer?
- Grows hemp for raw materials.
- Manufactures hemp oil.
- Processes hemp into various product forms.
- Sells hemp-based chewing gum under the YOOFORIC brand.
- Offers hemp-based tinctures under the YOOFORIC brand.
- Distributes products online through its e-commerce platform.
How Does CNFHF Make Money?
- Vertically integrated hemp production and processing.
- Direct-to-consumer sales through online channels.
- Focus on branded hemp-based products.
- Revenue generation through product sales.
What Industry Does CNFHF Operate In?
CanaFarma Hemp Products Corp. operates within the specialty and generic drug manufacturing industry, specifically focusing on hemp-derived products. The market for hemp-based products has grown rapidly in recent years, driven by increasing consumer interest in alternative health and wellness solutions. However, the industry is also characterized by intense competition, evolving regulations, and varying consumer perceptions. CanaFarma competes with other companies in the hemp space, as well as established players in the broader health and wellness market. Success in this industry requires effective branding, product innovation, and the ability to navigate the complex regulatory landscape.
Who Are CNFHF's Key Customers?
- Consumers seeking alternative health and wellness products.
- Individuals interested in the potential benefits of hemp oil.
- Customers purchasing products online.
- Retail consumers interested in hemp-based chewing gum and tinctures.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 60 |
| 2026-08-26 | 60 |
| 2026-08-29 | 60 |
| 2026-09-01 | 60 |
| 2026-09-04 | 60 |
| 2026-09-07 | 60 |
| 2026-09-10 | 60 |
What changed?
The score has stayed at 60.
Over the same 18 days the stock moved +0.0%.
Financial Health
CanaFarma Hemp Products Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -44.29 places it in the distress zone, a signal of elevated financial risk.
Company Profile
CanaFarma Hemp Products Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Phil Klauder. CNFHF has traded publicly since 2021.
CNFHF Financials
Bull Case vs Bear Case
Bull Case
- Established brand (YOOFORIC).
- Vertically integrated operations.
- Online distribution channel.
- Focus on hemp-based products.
Bear Case
- Negative profit margin.
- Limited product line.
- Small market capitalization.
- Dependence on the U.S. market.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
CNFHF Latest News
CNFHF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CNFHF.
Price Targets
Wall Street price target analysis for CNFHF.
CNFHF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CNFHF; grades run from A+ (80-100) to F (below 30).
Leadership: Phil Klauder
CEO
Phil Klauder serves as the CEO of CanaFarma Hemp Products Corp. His background includes experience in the consumer packaged goods and cannabis industries. He has held various leadership positions in sales, marketing, and operations. Klauder's expertise lies in developing and executing growth strategies for emerging brands. He brings a strong understanding of consumer behavior and market trends to CanaFarma.
Track Record: Under Phil Klauder's leadership, CanaFarma has focused on expanding its product line and distribution channels. He has overseen the launch of new products under the YOOFORIC brand and the development of the company's online platform. Klauder has also focused on building strategic partnerships to enhance CanaFarma's market reach. However, the company's financial performance remains a challenge.
CNFHF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that CanaFarma Hemp Products Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may be subject to greater risks due to less stringent regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier requires a higher degree of due diligence and risk assessment.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Low liquidity.
- Potential for fraud or manipulation.
- Lack of regulatory oversight.
- Higher price volatility.
- Verify the company's financial statements.
- Research the background of the company's management team.
- Assess the company's competitive position.
- Evaluate the company's regulatory compliance.
- Understand the company's business model.
- Check for any legal or regulatory issues.
- Consult with a financial advisor.
- Company has a functioning website.
- Products are available for sale online.
- CEO is publicly known.
- Company has a registered business address.
- Company has been in operation for several years.
CanaFarma Hemp Products Corp. Healthcare Stock: Key Questions Answered
Is CNFHF a good stock?
Stock Expert AI does not rate CNFHF buy, sell or hold. CanaFarma Hemp Products Corp. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What does CanaFarma Hemp Products Corp. do?
CanaFarma Hemp Products Corp. is involved in the cultivation, manufacturing, processing, and sale of hemp oil in the United States. The company offers hemp-based products, such as chewing gum and tinctures, under the YOOFORIC brand, primarily sold online.
What do analysts say about CNFHF stock?
There is currently no available analyst coverage for CanaFarma Hemp Products Corp. (CNFHF). The company's micro-cap status and OTC listing likely contribute to the lack of analyst interest.
What are the key factors to evaluate for CNFHF?
Evaluate CNFHF on fundamentals, analyst consensus, and risk factors. Investing in CanaFarma Hemp Products Corp. presents a high-risk, high-reward scenario. Not financial advice.
How frequently does CNFHF data refresh on this page?
CNFHF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven CNFHF's recent stock price performance?
CanaFarma Hemp Products Corp. (CNFHF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brand (YOOFORIC). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CNFHF overvalued or undervalued right now?
CanaFarma Hemp Products Corp. (CNFHF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of CNFHF?
Yes, most major brokerages offer fractional shares of CanaFarma Hemp Products Corp. (CNFHF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited and may not be fully up-to-date.
- OTC market stocks are inherently more risky than exchange-listed stocks.